Raymond James & Associates’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
GJL
JCP
PAIM
Raymond James & Associates's BXC Position: Q3 2024 in Review
Raymond James & Associates reduced its BlueLinx (BXC) stake by 46% in Q3 2024, selling an estimated $180K and leaving 2,034 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.
Raymond James & Associates first reported a position in BXC in Q2 2020 and has held it in 11 quarters since. The position peaked at $474K in Q1 2024. 167 funds tracked by Wall St. Rank hold BXC as of Q3 2024.
- Raymond James & Associates held 2,034 shares of BlueLinx worth $214K as of Q3 2024.
- Raymond James & Associates sold 1,766 BlueLinx shares in Q3 2024, an estimated $180K.
- BlueLinx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3606 holding.
- Raymond James & Associates first reported a position in BlueLinx in Q2 2020 and has held it in 11 quarters since.
- Raymond James & Associates's BlueLinx position peaked at $474K in Q1 2024.
- 167 funds tracked by Wall St. Rank held BlueLinx as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.